The Origins and Implications of Intratumor Heterogeneity

被引:139
|
作者
Michor, Franziska [1 ,3 ]
Polyak, Kornelia [2 ,4 ,5 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
CANCER STEM-CELLS; TUMOR HETEROGENEITY; STOCHASTIC DYNAMICS; MYELOID-LEUKEMIA; SOLID TUMORS; EVOLUTIONARY; MODEL; PROGRESSION; METASTASIS; RESISTANCE;
D O I
10.1158/1940-6207.CAPR-10-0234
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human tumors often display startling intratumor heterogeneity in various features including histology, gene expression, genotype, and metastatic and proliferative potential. This phenotypic and genetic heterogeneity plays an important role in neoplasia, cancer progression, and therapeutic resistance. In this issue of the journal (beginning on page 1388), Merlo et al. report their use of molecular data from 239 patients with Barrett's esophagus to evaluate the propensity of major diversity indices for predicting progression to esophageal adenocarcinoma. This work helps elucidate the implications of molecular heterogeneity for the evolution of neoplasia. Cancer Prev Res; 3(11); 1361-4. (C) 2010 AACR.
引用
收藏
页码:1361 / 1364
页数:4
相关论文
共 50 条
  • [1] Clinical implications of intratumor heterogeneity: challenges and opportunities
    Ramon y Cajal, Santiago
    Sese, Marta
    Capdevila, Claudia
    Aasen, Trond
    De Mattos-Arruda, Leticia
    Diaz-Cano, Salvador J.
    Hernandez-Losa, Javier
    Castellvi, Josep
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (02): : 161 - 177
  • [2] Clinical implications of intratumor heterogeneity: challenges and opportunities
    Santiago Ramón y Cajal
    Marta Sesé
    Claudia Capdevila
    Trond Aasen
    Leticia De Mattos-Arruda
    Salvador J. Diaz-Cano
    Javier Hernández-Losa
    Josep Castellví
    [J]. Journal of Molecular Medicine, 2020, 98 : 161 - 177
  • [3] Breast cancer intratumor genetic heterogeneity: causes and implications
    Ng, Charlotte K. Y.
    Pemberton, Helen N.
    Reis-Filho, Jorge S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) : 1021 - 1032
  • [4] Metabolomics reveals intratumor heterogeneity - Implications for precision medicine
    Liu, Xiaojing
    Locasale, Jason W.
    [J]. EBIOMEDICINE, 2017, 19 : 4 - 5
  • [5] Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment
    Mangano, Alberto
    Lianos, Georgios D.
    Mangano, Alessandro
    Boni, Luigi
    Dionigi, Gianlorenzo
    [J]. FUTURE ONCOLOGY, 2015, 11 (04) : 561 - 564
  • [6] Intratumor heterogeneity in HCC
    Friemel, Juliane
    Frick, Lukas
    Weber, Achim
    [J]. AGING-US, 2015, 7 (06): : 350 - 351
  • [7] INTRATUMOR IMMUNOLOGICAL HETEROGENEITY
    MILLER, FR
    GRISWOLD, DE
    HEPPNER, GH
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 27 - 27
  • [8] Dissecting intratumor heterogeneity in HCC: new research strategies and clinical implications
    Behrens, Shay
    Wang, Xin Wei
    [J]. CARCINOGENESIS, 2022, 43 (12) : 1103 - 1109
  • [9] Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
    Chowdhury, Saikat
    Hofree, Matan
    Lin, Kangyu
    Maru, Dipen
    Kopetz, Scott
    Shen, John Paul
    [J]. CANCERS, 2021, 13 (19)
  • [10] Evolutionary Dynamics of Intratumor Heterogeneity
    Iwasa, Yoh
    Michor, Franziska
    [J]. PLOS ONE, 2011, 6 (03):